Genetic Signatures Ltd has released a press release.
Regulatory and Patent approval
Filed with ASX ·
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- Results of Flavivirus Clinical Trial
- GSS Launches Sexually Transmitted Infection (STI) Kit
- Appendix 4D - Half Yearly Report and Accounts
- 2016 AGM MD and CEO Presentation
- STI Detection Kit Clinical Validation Trial Results
Later from Genetic Signatures
- Appendix 4E and 2017 Financial Report
- 2017 AGM Presentation
- Appendix 4D and Half Year Financial Statements
- Positive Trial Results Presented at ECCMID
- TGA registration for superbug detection kits
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures